MF’s exposure to bank stocks soars in Feb
24/03/2015 15:06
Mutual Fund is betting big on banking stocks as its equity exposure has surged for the fifth consecutive month to a new high in February 2015, said the media report. Mutual fund managers have raised exposure to a historic high of nearly Rs 78,000 crore in banking stocks in February 2015, from Rs 32,225 crore in February 2014, according to data available with the Securities and Exchange Board of India (Sebi). MF investments in banking stocks stood at Rs 77,805 crore as of February 2015, accounting for 21.32 per cent of their total equity assets under management (AUM) of Rs 3.65 lakh crore, the report said. MFs have been increasing their exposure to banking shares since January last year but their investment level in the sector dropped in September 2014. The industry again increased the exposure in October and the momentum continued till February 2015. In addition, Software was the second most preferred sector last month with an exposure of Rs 38,514 crore, followed by pharmaceutical at Rs 23,980 crore.
24/03/2015 15:06
Mutual Fund is betting big on banking stocks as its equity exposure has surged for the fifth consecutive month to a new high in February 2015, said the media report. Mutual fund managers have raised exposure to a historic high of nearly Rs 78,000 crore in banking stocks in February 2015, from Rs 32,225 crore in February 2014, according to data available with the Securities and Exchange Board of India (Sebi). MF investments in banking stocks stood at Rs 77,805 crore as of February 2015, accounting for 21.32 per cent of their total equity assets under management (AUM) of Rs 3.65 lakh crore, the report said. MFs have been increasing their exposure to banking shares since January last year but their investment level in the sector dropped in September 2014. The industry again increased the exposure in October and the momentum continued till February 2015. In addition, Software was the second most preferred sector last month with an exposure of Rs 38,514 crore, followed by pharmaceutical at Rs 23,980 crore.
